Principal Financial Group
PCVX icon

Principal Financial Group’s Vaxcyte PCVX Stock Holding History

Principal Financial Group’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
7,711
+2,436
+46% +$132K ﹤0.01% 2016
2026
Q1 		$307K Buy
5,275
+343
+7% +$18.6K ﹤0.01% 2069
2025
Q4 		$228K Sell
4,932
-3,062
-38% -$137K ﹤0.01% 2115
2025
Q3 		$288K Sell
7,994
-618
-7% -$20.5K ﹤0.01% 2125
2025
Q2 		$280K Sell
8,612
-460,949
-98% -$15.1M ﹤0.01% 2083
2025
Q1 		$17.7M Buy
469,561
+160,622
+52% +$12.8M 0.01% 907
2024
Q4 		$25.3M Buy
308,939
+256,237
+486% +$25.4M 0.01% 723
2024
Q3 		$6.02M Buy
52,702
+34,287
+186% +$3.09M ﹤0.01% 1499
2024
Q2 		$1.39M Sell
18,415
-6,182
-25% -$421K ﹤0.01% 1818
2024
Q1 		$1.68M Buy
24,597
+2,589
+12% +$179K ﹤0.01% 1800
2023
Q4 		$1.38M Buy
22,008
+376
+2% +$19.5K ﹤0.01% 1802
2023
Q3 		$1.1M Sell
21,632
-524
-2% -$25.9K ﹤0.01% 1828
2023
Q2 		$1.11M Buy
22,156
+4,848
+28% +$230K ﹤0.01% 1831
2023
Q1 		$649K Sell
17,308
-1,154
-6% -$49K ﹤0.01% 1917
2022
Q4 		$885K Buy
18,462
+4,190
+29% +$164K ﹤0.01% 1875
2022
Q3 		$342K Sell
14,272
-225
-2% -$5.7K ﹤0.01% 2046
2022
Q2 		$315K Buy
+14,497
New +$335K ﹤0.01% 2163
2021
Q4 		– Sell
-10,121
Closed -$257K – 2600
2021
Q3 		$257K Sell
10,121
-1,641
-14% -$39.8K ﹤0.01% 2349
2021
Q2 		$265K Buy
11,762
+448
+4% +$9.17K ﹤0.01% 2400
2021
Q1 		$223K Buy
11,314
+797
+8% +$20.1K ﹤0.01% 2354
2020
Q4 		$279K Buy
+10,517
New +$391K ﹤0.01% 2252

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Principal Financial Group's PCVX Position: Q2 2026 in Review

Principal Financial Group increased its Vaxcyte (PCVX) stake by 46% in Q2 2026, buying an estimated $132K and bringing the position to 7,711 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Principal Financial Group first reported a position in PCVX in Q4 2020 and has held it in 21 quarters since. The position peaked at $25.3M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Principal Financial Group held 7,711 shares of Vaxcyte worth $448K as of Q2 2026.
  • Principal Financial Group bought 2,436 Vaxcyte shares in Q2 2026, an estimated $132K.
  • Vaxcyte made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2016 holding.
  • Principal Financial Group first reported a position in Vaxcyte in Q4 2020 and has held it in 21 quarters since.
  • Principal Financial Group's Vaxcyte position peaked at $25.3M in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.